A decision support framework for optimal vaccine distribution across a multi-tier cold chain network

TL;DR

This paper introduces a decision support framework for optimizing vaccine distribution in multi-tier cold chain networks, incorporating multi-period planning, multiple vaccines, and robustness to uncertainties, demonstrated through a case study in Bihar with COVID-19 vaccines.

Contribution

The paper develops a comprehensive multi-period optimization framework for vaccine distribution that includes multiple vaccines, uncertainty modeling, and practical implementation insights.

Findings

Robust optimization outperforms deterministic models under uncertainty.

Model helps assess impact of storage and transportation capacities.

Framework effectively guides vaccine selection and distribution planning.

Abstract

In this paper, we present a decision support framework for optimizing multiple aspects of vaccine distribution across a multitier cold chain network. We propose two multi-period optimization formulations within this framework: first to minimize inventory, ordering, transportation, personnel and shortage costs associated with a single vaccine; the second being an extension of the first for the case when multiple vaccines with differing efficacies and costs are available for the same disease. Vaccine transportation and administration lead times are also incorporated within the models. We also develop robust optimization versions of the single vaccine model to account for the impact of uncertainty in model parameters on the optimal vaccine distribution solution. We use the case of the Indian state of Bihar and COVID-19 vaccines to illustrate the implementation of the framework. We present computational experiments to demonstrate: (a) the organization of the model outputs; (b) how the models can be used to assess the impact of cold chain point storage capacities, transportation vehicle capacities, and manufacturer capacities on the optimal vaccine distribution pattern; and (c) the impact of vaccine efficacies and associated costs such as ordering and transportation costs on the vaccine selection decision informed by the model. We then consider the computational expense of the framework for realistic problem instances, and suggest multiple preprocessing techniques to reduce their computational burden. Finally, we also demonstrate how the robust versions of the single vaccine model outperform the deterministic version under multiple levels of uncertainty in key model parameters. Our study presents public health authorities and other stakeholders with a vaccine distribution and capacity planning tool for multi-tier cold chain networks.